| Literature DB >> 31279093 |
Juichi Fujimori1, Toshiyuki Takahashi2, Yuki Matsumoto3, Kazuo Fujihara4, Yoshiki Takai3, Tatsuro Misu5, Ichiro Nakashima6.
Abstract
Recently, we documented two Japanese cases of myelin-oligodendrocyte glycoprotein (MOG) antibody-associated relapsing encephalitis among patients who had been diagnosed with probable neuro-Behçet's disease (NBD). They presented partial systemic BD symptoms, brainstem lesions, and the human leukocyte antigen (HLA) B51 allele and responded well to steroid therapy. Our cases suggest that we need to differentiate anti-MOG antibody-associated encephalitis from probable NBD because both disorders can present with brainstem or cerebral lesions, CSF pleocytosis, and elevated levels of CSF IL-6 and respond to steroid treatment. Furthermore, oral ulceration, skin lesions, and HLA-B51 might be observed nonspecifically in patients with anti-MOG antibody-associated encephalitis.Entities:
Keywords: Differential diagnosis; Encephalitis; Myelin-oligodendrocyte glycoprotein; Neuro-Behçet's disease
Year: 2019 PMID: 31279093 DOI: 10.1016/j.jneuroim.2019.577002
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478